MHK
49
4
CF
57
-2
EMN
60
4
LH
43
-2
STZ
54
-3
MET
72
5
NDAQ
62
2
R
71
4
CINF
53
2
CHRW
56
-3
TJX
64
2
DHI
48
4
PBI
69
4
SCHW
62
-2
GIS
31
3
EXC
53
-3
EQT
57
-2
DE
63
3
ROP
62
3
ILMN
42
5
MHK
49
4
CF
57
-2
EMN
60
4
LH
43
-2
STZ
54
-3
MET
72
5
NDAQ
62
2
R
71
4
CINF
53
2
CHRW
56
-3
TJX
64
2
DHI
48
4
PBI
69
4
SCHW
62
-2
GIS
31
3
EXC
53
-3
EQT
57
-2
DE
63
3
ROP
62
3
ILMN
42
5
Financhill
Back

Vor Biopharma Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18

VOR
Vor Biopharma

Last Price:
0.79
Seasonality Move:
7.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VOR is experiencing slight buying pressure.

Vor Biopharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.83 Sell
20-day SMA: 0.84 Sell
50-day SMA: 0.78 Buy
200-day SMA: 1.31 Sell
8-day EMA: 0.82 Sell
20-day EMA: 0.82 Sell
50-day EMA: 0.82 Sell
200-day EMA: 1.32 Sell

Vor Biopharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 46.96 Sell
Chaikin Money Flow: 27768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.72 - 0.9) Sell
Bollinger Bands (100): (0.73 - 0.97) Sell

Vor Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Vor Biopharma Stock

Is Vor Biopharma Stock a Buy?

  • Vor Biopharma share price is 0.79 while VOR 8-day simple moving average is 0.83, which is a Sell signal.
  • The stock price of VOR is 0.79 while Vor Biopharma 20-day SMA is 0.84, which makes it a Sell.
  • Vor Biopharma 50-day simple moving average is 0.78 while VOR share price is 0.79, making it a Buy technically.
  • VOR stock price is 0.79 and Vor Biopharma 200-day simple moving average is 1.31, creating a Sell signal.

VOR Technical Analysis vs Fundamental Analysis

Sell
18
Vor Biopharma (VOR) is a Sell

Is Vor Biopharma a Buy or a Sell?

  • Vor Biopharma stock is rated a Sell
    The current Vor Biopharma [VOR] share price is $0.79. The Score for VOR is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.

Vor Biopharma Stock Info

Market Cap:
54.25M
Price in USD:
0.79
Share Volume:
455.15K

Vor Biopharma 52-Week Range

52-Week High:
3.14
52-Week Low:
0.63
Sell
18
Vor Biopharma (VOR) is a Sell

Vor Biopharma Share Price Forecast

  • What is the Vor Biopharma stock price today?
    The Vor Biopharma stock price is 0.79 USD today.
  • Will VOR stock go up or go down?
    Vor Biopharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Vor Biopharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vor Biopharma is overvalued.

Is Vor Biopharma Stock a Buy?

  • Vor Biopharma share price is 0.79 while VOR 8-day exponential moving average is 0.82, which is a Sell signal.
  • The stock price of VOR is 0.79 while Vor Biopharma 20-day EMA is 0.82, which makes it a Sell.
  • Vor Biopharma 50-day exponential moving average is 0.82 while VOR share price is 0.79, making it a Sell technically.
  • VOR stock price is 0.79 and Vor Biopharma 200-day simple moving average is 1.32, creating a Sell signal.

Fundamental Analysis of Vor Biopharma

Is Vor Biopharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.32 per share.

Technical Analysis of Vor Biopharma

Should I short Vor Biopharma stock?

* Vor Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.